STAAR Surgical Co Proceeds from Issuance or Sale of Equity
STAAR Surgical Co (STAA) reported Proceeds from Issuance or Sale of Equity of $72.15 million for the 12-month period ending 2018-12-28, per its 10-K filed 2019-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2019-02-21
- STAAR Surgical Co proceeds from issuance or sale of equity for fiscal 2018 was $72.15M.
- STAAR Surgical Co proceeds from issuance or sale of equity for fiscal 2010 was $8.50M.
| Period end | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|
| 2018-12-28 | $72.15M 10-K · filed 2019-02-21 |
| 2010-01-01 | $8.50M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |